UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 179

Sortiert nach

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

Annals of oncology, 2022-01, Vol.33 (1), p.42-56

2022

Volltextzugriff (PDF)

Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer

Annals of oncology, 2024-02, Vol.35 (2), p.183-189

2024

Volltextzugriff (PDF)

Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii738-viii738

2018

Volltextzugriff (PDF)

Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma

British journal of surgery, 2021-10, Vol.108 (10), p.1207-1215

2021

Volltextzugriff (PDF)

MS06.03 The Role of Surgical Resection

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S261-S262

Sepesi, B.

2018

Volltextzugriff (PDF)

Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience

Diseases of the esophagus, 2020-03, Vol.33 (3)

2020

Volltextzugriff (PDF)

Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii680-viii680

2018

Volltextzugriff (PDF)

Patient-Reported Symptoms: Differences Between Men and Women Following Pulmonary Resection

International journal of radiation oncology, biology, physics, 2017-05, Vol.98 (1), p.240-240

2017

Volltextzugriff (PDF)

Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non–Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2017-05, Vol.98 (1), p.223-223

2017

Volltextzugriff (PDF)

Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience

The Annals of thoracic surgery, 2019-08, Vol.108 (2), p.370-376

2019

Volltextzugriff (PDF)

Esophageal Tumor Thickness on Computed Tomography as a Predictor of Residual Tumor in Esophageal Adenocarcinoma Following Preoperative Chemoradiation

The Journal of surgical research, 2014-02, Vol.186 (2), p.680-680

2014

Volltextzugriff (PDF)

Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy

Modern pathology, 2024-01, Vol.37 (1), p.100353-100353, Article 100353

2024

Volltextzugriff (PDF)

2334P Pathologic patterns following different neoadjuvant therapies in non-small cell lung cancer (NSCLC)

Annals of oncology, 2023-10, Vol.34, p.S1191-S1191

2023

Volltextzugriff (PDF)

PP01.18 Surgical Resection after Targeted Therapy in Stage IV NSCLC: Nuances and Considerations

Journal of thoracic oncology, 2023-03, Vol.18 (3), p.e18-e18

2023

Volltextzugriff (PDF)

EP14.03-06 PULS - An International Collaboration for Collection and Assessment of Data from Patients with PUL Monary Artery Sarcoma

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S723

2023

Volltextzugriff (PDF)

113P Clinical overstaging in pathologic stage I non-small cell lung cancer: Prognostic implications

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S104-S105

2023

Volltextzugriff (PDF)

PP01.06 Circulomic Variables may Predict Pathologic Staging Preoperatively in Treatment-Naïve Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2023-03, Vol.18 (3), p.e12-e12

2023

Volltextzugriff (PDF)

Lung Cancer Patient Perceptions of the Value of an Outreach Thoracic Surgical Clinic

The Annals of thoracic surgery, 2019-08, Vol.108 (2), p.358-362

2019

Volltextzugriff (PDF)

P2.02-041 Update on Prospective Immunogenomic Profiling of Non-Small Cell Lung Cancer (ICON Project)

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2114-S2114

2017

Volltextzugriff (PDF)

123P Clinical and environment factors impacting malignant pleural mesothelioma prognosis

Annals of oncology, 2022-04, Vol.33, p.S89

2022

Volltextzugriff (PDF)

LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC

Annals of oncology, 2023-10, Vol.34, p.S1295-S1295

2023

Volltextzugriff (PDF)

OA13.01 S1619 A Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and Maintenance for Resectable Pleural Mesothelioma

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S870-S870

2021

Volltextzugriff (PDF)

EP02.04-005 Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ NSCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S233-S234

2022

Volltextzugriff (PDF)

FP05.03 Association between Baseline Tumor Thickness and Response to Neoadjuvant Chemotherapy in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S200-S200

2021

Volltextzugriff (PDF)

EP07.05-03 Neoadjuvant Chemotherapy or Chemo-IO in Resectable KRAS-Mutated Non-small Cell Lung Cancer (NSCLC) Patients: Single Center Experience

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S558-S559

2023

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(170)

Publikationsform

Artikel
(179)

Sprache

Englisch
(179)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Life Sciences & Biomedicine
(105)
Humans
(73)
Surgery
(73)
Respiratory System
(64)
Cardiac & Cardiovascular Systems
(53)
Cardiovascular System & Cardiology
(53)
Retrospective Studies
(45)
Female
(37)
Male
(37)
Aged
(36)
Middle Aged
(36)
Oncology
(29)
Lung Neoplasms - Surgery
(28)
Lung Cancer
(27)
Treatment Outcome
(24)
Neoplasm Staging
(22)
Lung Neoplasms - Pathology
(21)
Carcinoma, Non-Small-Cell Lung - Surgery
(20)
Lung Neoplasms - Mortality
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer

Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)

Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma

MS06.03 The Role of Surgical Resection

Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience

Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC)

Patient-Reported Symptoms: Differences Between Men and Women Following Pulmonary Resection

Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non–Small Cell Lung Cancer

Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience

Esophageal Tumor Thickness on Computed Tomography as a Predictor of Residual Tumor in Esophageal Adenocarcinoma Following Preoperative Chemoradiation

Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy

2334P Pathologic patterns following different neoadjuvant therapies in non-small cell lung cancer (NSCLC)

PP01.18 Surgical Resection after Targeted Therapy in Stage IV NSCLC: Nuances and Considerations

EP14.03-06 PULS - An International Collaboration for Collection and Assessment of Data from Patients with PUL Monary Artery Sarcoma

113P Clinical overstaging in pathologic stage I non-small cell lung cancer: Prognostic implications

PP01.06 Circulomic Variables may Predict Pathologic Staging Preoperatively in Treatment-Naïve Non-Small Cell Lung Cancer

Lung Cancer Patient Perceptions of the Value of an Outreach Thoracic Surgical Clinic

P2.02-041 Update on Prospective Immunogenomic Profiling of Non-Small Cell Lung Cancer (ICON Project)

123P Clinical and environment factors impacting malignant pleural mesothelioma prognosis

LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC

OA13.01 S1619 A Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and Maintenance for Resectable Pleural Mesothelioma

EP02.04-005 Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ NSCLC

FP05.03 Association between Baseline Tumor Thickness and Response to Neoadjuvant Chemotherapy in Malignant Pleural Mesothelioma

EP07.05-03 Neoadjuvant Chemotherapy or Chemo-IO in Resectable KRAS-Mutated Non-small Cell Lung Cancer (NSCLC) Patients: Single Center Experience

Suchergebnisse filtern